Alternatives to Atlas Discovery

All-in-human AI foundation models that predict brain activity and therapy response for CNS drug programs

Clinical-stage AI drug discovery company running a wet-and-dry lab-in-the-loop engine with 2M weekly experiments and a 50+ PB phenomics dataset

Generative AI drug discovery suite covering target ID, molecule design, biologics engineering and clinical trial prediction.

Clinical-stage TechBio company using cellular imaging and AI to discover drugs, with a Phase 1 MALT1 inhibitor and a Genentech neuroscience collaboration.

AI agents that assemble clinical evidence into quantitative models for trial design, dose selection and go/no-go decisions.

Owkin's K Pro is an autonomous AI scientist agent that informs biopharma R&D, clinical trial and portfolio decisions.

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease through partnership-led discovery.

FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.

AI-native biotech pairing 20+ petabytes of cellular experiments with population genetics to find causal drug targets

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

PathAI is an enterprise digital pathology platform for diagnostic accuracy and biopharma drug development.

An AI co-scientist that chains 150+ biological tools to run multi-omics, clinical genomics, and drug discovery analysis from plain-language prompts.

HealthKey scans your EHR daily and emails you clinical trial patients who match your protocol's eligibility criteria.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

PicnicAI turns patient health records into clinical research data and real-world evidence.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Silico is Goodfire's interpretability agent for understanding, debugging, and controlling the internals of your AI models

Oncology real-world evidence platform turning patient data into AI-assisted cancer research insights.

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

Physics-based simulation plus AI for molecular discovery across drug and materials design.

Tempus is an AI precision oncology platform that pairs tumor DNA/RNA sequencing with a 7M+ de-identified clinical record library for treatment and trial

Preclinical biotech using causal AI models X-Cell and X-Atlas/Pisces to predict how biology responds to perturbation, from target to patient.

Exscientia now lives inside Recursion — an AI drug discovery engine built on automated wet labs and a 50+ PB dataset.

AI platform that designs and predicts molecular constructs for gene and RNA therapies before they reach the lab

AI-CRISPR target discovery platform used by pharma partners to find causal immunology and oncology targets before committing to a program.

Cellbyte is an AI workspace for pharmaceutical Pricing & Market Access teams, turning HTA and pricing research from weeks into minutes.

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

AI-driven scientific diligence for pharma BD, biotech, and life science investors evaluating in-licensing and M&A targets.

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.